New Delhi: The Indian government is holding talks with Johnson and Johnson for its single dose COVID-19 vaccine.
“We are in talks with Johnson & Johnson regarding their single-dose vaccine. Their vaccine is being produced outside,” Niti Ayog (health) member Dr VK Paul said during a press briefing on Friday.
Dr Paul also informed that the vaccine developed by the US pharmaceutical giant will be produced at Hyderabad-based Indian company Bio E.
“As per the plan, this vaccine will also be produced in Hyderabad’s Biological E,” Dr Paul said.
Johnson & Johnson recently said its vaccine is far more effective in neutralising Delta variants than against Beta variants.
Besides Covishield and Covaxin, India has approved two other vaccines so far — Moderna and Sputnik V.
Bhubaneswar: A woman died while her younger sister is battling for life after an alleged…
Madurai: Founder of KIIT, KISS, and KIMS, Achyuta Samanta has been honoured with Lifetime Achievement…
Koraput: Three persons died while one was seriously injured after a truck rammed into a…
New Delhi: The BJP-led NDA government will introduce 15 bills, including one to amend the…
Bhubaneswar: A newborn baby, who was allegedly sold by her parents in Odisha's Balangir district,…
Mumbai: Exit polls have given Bharatiya Janata Party-led Mahayuti alliance an edge in the neck-to-neck…
Cuttack: The Orissa High Court has put the BDA's order for demolition of controversial Shree…
New York: Amid reports of deteriorating health of astronauts Sunita Williams and Butch Wilmore, it…